Cambridge Advisors’s Charles River Laboratories CRL Stock Holding History

Cambridge Advisors’s Portfolio CRL Stock Details CRL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$272K	Hold	1,200	–	–	0.05%	164
2026 Q1	$207K	Hold	1,200	–	–	0.04%	175
2025 Q4	$239K	Buy	+1,200	New	+$218K	0.05%	166
2025 Q1	–	Sell	-1,200	Closed	-$222K	–	176
2024 Q4	$222K	Hold	1,200	–	–	0.05%	163
2024 Q3	$236K	Hold	1,200	–	–	0.05%	159
2024 Q2	$248K	Hold	1,200	–	–	0.06%	157
2024 Q1	$325K	Hold	1,200	–	–	0.08%	138
2023 Q4	$284K	Hold	1,200	–	–	0.07%	142
2023 Q3	$235K	Hold	1,200	–	–	0.06%	151
2023 Q2	$252K	Hold	1,200	–	–	0.06%	147
2023 Q1	$242K	Hold	1,200	–	–	0.06%	165
2022 Q4	$261K	Hold	1,200	–	–	0.07%	154
2022 Q3	$236K	Hold	1,200	–	–	0.07%	154
2022 Q2	$257K	Hold	1,200	–	–	0.07%	157
2022 Q1	$341K	Hold	1,200	–	–	0.08%	141
2021 Q4	$452K	Sell	1,200 -100	-8%	-$38.9K	0.1%	130
2021 Q3	$536K	Sell	1,300 -200	-13%	-$83.1K	0.13%	113
2021 Q2	$555K	Hold	1,500	–	–	0.13%	107
2021 Q1	$435K	Hold	1,500	–	–	0.11%	116
2020 Q4	$375K	Sell	1,500 -300	-17%	-$71.4K	0.1%	119
2020 Q3	$408K	Hold	1,800	–	–	0.12%	101
2020 Q2	$314K	Hold	1,800	–	–	0.1%	115
2020 Q1	$227K	Sell	1,800 -200	-10%	-$30K	0.08%	126
2019 Q4	$306K	Hold	2,000	–	–	0.09%	121
2019 Q3	$265K	Hold	2,000	–	–	0.09%	113
2019 Q2	$284K	Hold	2,000	–	–	0.09%	113
2019 Q1	$291K	Hold	2,000	–	–	0.1%	114
2018 Q4	$226K	Hold	2,000	–	–	0.08%	122
2018 Q3	$269K	Hold	2,000	–	–	0.09%	121
2018 Q2	$225K	Hold	2,000	–	–	0.08%	129
2018 Q1	$213K	Hold	2,000	–	–	0.08%	133
2017 Q4	$219K	Hold	2,000	–	–	0.08%	128
2017 Q3	$216K	Hold	2,000	–	–	0.08%	127
2017 Q2	$202K	Buy	+2,000	New	+$184K	0.08%	128

Other funds holding CRL

CIM

Confluence Investment Management St. Louis, Missouri $6.4B AUM 9.79% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

CPCPP

Canada Post Corporation Pension Plan Toronto, Canada $2.87B AUM 37.96% 1-Year Est. Return

PensionDanmark Copenhagen O, Denmark $12B AUM

CNB

Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return

COPPSERS

Commonwealth of Pennsylvania Public School Employees Retirement System Harrisburg, Pennsylvania $20.6B AUM 37.37% 1-Year Est. Return

MPPW

Mitchell & Pahl Private Wealth Oklahoma City, Oklahoma $272M AUM 29.72% 1-Year Est. Return

YCM

Yousif Capital Management Bloomfield Hills, Michigan $8.94B AUM 42.6% 1-Year Est. Return

Cambridge Advisors's CRL Position: Q2 2026 in Review

Cambridge Advisors held its Charles River Laboratories (CRL) position steady in Q2 2026 at 1,200 shares worth $272K. The position accounts for 0.05% of the portfolio, ranked #164.

Cambridge Advisors first reported a position in CRL in Q2 2017 and has held it in 34 quarters since. The position peaked at $555K in Q2 2021. 60 funds tracked by Wall St. Rank hold CRL as of Q2 2026.

Cambridge Advisors held 1,200 shares of Charles River Laboratories worth $272K as of Q2 2026.
Cambridge Advisors left its Charles River Laboratories share count unchanged in Q2 2026.
Charles River Laboratories made up 0.05% of Cambridge Advisors's portfolio in Q2 2026, its #164 holding.
Cambridge Advisors first reported a position in Charles River Laboratories in Q2 2017 and has held it in 34 quarters since.
Cambridge Advisors's Charles River Laboratories position peaked at $555K in Q2 2021.
60 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2026.

Based on Cambridge Advisors's 13F filing for Q2 2026, filed 16 Jul 2026.